The Efficacy and Safety of Endovascular Treatment for Acute Mild Basilar Artery Occlusion
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorFeng Gao
About this trial
This study assesses the efficacy and safety of endovascular treatment for acute mild basilar artery occlusion within a multicenter, prospective, open-label, endpoint-blinded, randomized controlled clinical trial.
Eligibility criteria
Qualifiers
Age≥18
Acute ischemic stroke in posterior circulation, the time from stroke onset (or finally found normal) to randomization was within 24 hours
Acute basilar artery occlusion confirmed by CTA,MRA,or DSA
NIHSS score≥2 points and<10 points from the onset of the disease to before randomization
Disqualifiers
Any sign of intracranial hemorrhage (except microbleeds) on brain imaging prior to randomization
Complete cerebellar infarct with significant mass effect, or bilateral thalamic infarction as evidenced by baseline neuroimaging
Known or highly suspected chronic occlusion of basilar artery
History of contraindication for contrast medium (except mild rash)
Trial design
Treatments tested in this trial
- Endovascular Recanalization Strategy
- Best Medical Management
Treatment groups
230 Participants
are divided into 2 treatment groupsSponsors and collaborators
Feng Gao
Lead sponsor
Beijing Tiantan Hospital
Sponsor institution
Source ClinicalTrials.gov